Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand

Go back to Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
(NASDAQ: EOLS) Delayed: 7.86 -0.15 (1.87%)
Previous Close $8.01    52 Week High
Open $8.00    52 Week Low
Day High $8.00    P/E N/A 
Day Low $7.81    EPS
Volume 1,181,608